Flinton Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $253K | Buy |
9,212
+336
| +4% | +$9.23K | 0.01% | 617 |
|
|
2019
Q2 | $294K | Hold |
8,876
| – | – | 0.01% | 611 |
|
|
2019
Q1 | $311K | Hold |
8,876
| – | – | 0.01% | 586 |
|
|
2018
Q4 | $295K | Hold |
8,876
| – | – | 0.01% | 565 |
|
|
2018
Q3 | $447K | Buy |
8,876
+1,624
| +22% | +$81.8K | 0.01% | 518 |
|
|
2018
Q2 | $434K | Hold |
7,252
| – | – | 0.01% | 460 |
|
|
2018
Q1 | $332K | Buy |
7,252
+308
| +4% | +$14.1K | 0.01% | 527 |
|
|
2017
Q4 | $277K | Buy |
6,944
+1,456
| +27% | +$58.1K | 0.01% | 580 |
|
|
2017
Q3 | $219K | Buy |
5,488
+728
| +15% | +$29.1K | 0.01% | 596 |
|
|
2017
Q2 | $205K | Buy |
4,760
+2,240
| +89% | +$96.5K | 0.01% | 576 |
|
|
2017
Q1 | $79K | Buy |
2,520
+252
| +11% | +$7.9K | ﹤0.01% | 675 |
|
|
2016
Q4 | $57K | Buy |
+2,268
| New | +$57K | ﹤0.01% | 696 |
|